- The
Green Organic Dutchman produces high-quality, organic cannabis for the
medicinal and recreational adult use markets from purpose-built,
state-of-the-art facilities
- The
company has confirmed higher demand for premium organic cannabis
- TGOD
has also announced positive results from its pharmacokinetic study of
innovative cannabinoid technology
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX:
TGODF) is an international, premium organic cannabis company based in
Mississauga, Ontario. The company produces high-quality, organic medical and
recreational adult use cannabis using organic craft growing principles. TGOD
plans on commercializing organic cannabinoid dissolvables in Canada beginning
in December 2019 under the TGOD-Infusers line of premium cannabis products, and
results from a recent study have given support to that move. Additionally, TGOD
was able to report strong demand for its premium organic cannabis following its
Ontario launch and fast-tracked shipments.
Following its Ontario launch and fast-tracked shipments,
TGOD reported that there is a strong demand for its premium organic
cannabis (http://ibn.fm/wOW3S).
After the August launch, initial demand surpassed expectations. The company’s
high-THC (tetrahydrocannabinol) signature strain, Unite Organic, performed well
both online and at dispensaries, resulting in a second order from the Ontario
Cannabis Store – earlier than initially anticipated. The strong launch marks
TGOD’s successful entrance into the Canadian recreational market.
While cannabis companies abound, TGOD continues to impress
with its organic emphasis and the overall quality of its products. TGOD’s
cannabis is grown in its proprietary living soil, in accordance with
all-natural principles. Moreover, its growing process is certified organic by
Pro-Cert and ECOCERT, two top organic certification bodies. Of note is the fact
that, according to a 2019 study conducted by Hill & Knowlton, more than 50
percent of recreational consumers intending to purchase cannabis stated that it
is important that their cannabis be organic, and over 60 percent of medical
patients prefer organic cannabis. As one of the few certified-organic companies
in Canada, these numbers give TGOD an edge in the market.
While TGOD’s premium cannabis products are thriving, the
company also plans on introducing organic CBD-dissolvables to the market. In
line with that goal, TGOD and Caliper Foods recently reported positive results
from a pharmacokinetic study of proprietary, water-soluble cannabinoid
technology (http://ibn.fm/JdgjH).
The two companies revealed the results of a preliminary human pharmacokinetic
(PK) study of Caliper CBD, Caliper Foods’ proprietary tasteless, odorless,
water-soluble powder, which can be added to almost any food or beverage.
Caliper Foods is a best-in-class provider of water-soluble cannabinoid
products.
In the study, half of the participants were administered 30
milligrams of Caliper Foods’ water-soluble CBD powder in eight ounces of water;
the other half received 30 milligrams of CBD dispersed in MCT oil. Early data
shows that the group that received Caliper CBD demonstrated speedier onset
within 15 minutes, with higher concentrations attained at 15 minutes versus the
maximum concentration attained at 45 minutes with the CBD-in-oil formulation,
and a 4.5-fold higher observed total bioavailability.
“We are thrilled with the results of this preliminary PK
study, which demonstrate the consistency and precision of Caliper Foods’ proven
proprietary technology, which is already available in Colorado and which TGOD
will commercialize in Canada,” TGOD Chief Science Officer Dr. Rav Kumar stated
in a news release (http://ibn.fm/J5bPQ).
“Based on this early data, Caliper CBD provides a higher and faster absorption
level when compared with CBD-infused oil, which opens a number of possibilities
for both the medical and adult-use markets.”
With its proven management team and state-of-the-art
facilities, TGOD continues to focus on providing a slate of premium
consumer-preferred products. The company offers investors potential return on
investment as it looks to grow via strategic international opportunities.
TGOD’s hybrid facilities represent important advantages over indoor and outdoor
greenhouses and set the stage for lower capex and greater profits.
TGOD’s operational emphasis is on medical cannabis markets
in Canada, Europe, the Caribbean and Latin America, as well as the Canadian
adult-use market. The company’s strategy is to grow organically and at low
costs, resulting in a product that demands a premium in the marketplace,
thereby increasing the company’s margins.
For more information, visit the company’s website at www.TGOD.ca
NOTE TO INVESTORS: The latest news and updates
relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
